GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134 | -28.3% | 46,600 | -5.1% | 0.00% | – |
| Q2 2023 | $187 | +105.5% | 49,100 | +0.4% | 0.00% | – |
| Q1 2023 | $91 | -19.5% | 48,900 | -0.2% | 0.00% | – |
| Q4 2022 | $113 | -99.9% | 49,000 | -2.6% | 0.00% | – |
| Q3 2022 | $162,000 | -40.9% | 50,300 | +0.8% | 0.00% | – |
| Q2 2022 | $274,000 | +398.2% | 49,900 | +111.4% | 0.00% | – |
| Q1 2022 | $55,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,962,399 | $4,513,518 | 0.88% |
| Cheyne Capital Management (UK) LLP | 98,120 | $225,676 | 0.39% |
| Orbimed Advisors | 7,884,870 | $18,135,201 | 0.35% |
| Vivo Capital, LLC | 961,358 | $2,211 | 0.26% |
| EcoR1 Capital, LLC | 3,343,202 | $7,689,365 | 0.23% |
| Capital International, Inc./CA/ | 2,942,807 | $6,768,456 | 0.15% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $22,774,462 | 0.13% |
| Capital International Sarl | 297,193 | $683,544 | 0.05% |
| FEDERATED HERMES, INC. | 1,298,578 | $2,986,729 | 0.01% |
| Schonfeld Strategic Advisors LLC | 374,841 | $862,134 | 0.01% |